When Are Sleep Medications Used?
Reviewed by our editorial team
Last updated: 2026-04-01
Quick Answer
Sleep medications are most appropriate for acute, short-term insomnia in specific circumstances. For chronic insomnia, CBT-I is the first-line treatment. Some medications are appropriate for long-term use; others carry risks of dependency, tolerance, and rebound.
Sleep medications are among the most commonly prescribed drugs worldwide, yet their appropriate use is widely misunderstood. They are not a universal solution for all sleep problems, nor are they categorically to be avoided — they have specific indications, varying risk profiles, and important limitations that determine when they are the right choice.
The current consensus in sleep medicine, reflected in guidelines from the American Academy of Sleep Medicine and the American College of Physicians, is that Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment for chronic insomnia disorder. Sleep medication is appropriate in specific situations — but understanding those situations is essential for appropriate use.
When Medication Is Appropriate
Sleep medication is most clearly indicated for acute, situational insomnia — sleep disruption clearly linked to an identifiable stressor (bereavement, illness, major life stress) that is expected to resolve within days to weeks. In this context, a short course of medication can prevent the behavioral perpetuation of acute insomnia (the conditioned arousal and anxiety about sleep that develops when prolonged wakefulness in bed reinforces insomnia patterns).
Sleep medication may also be appropriate as an adjunct to CBT-I in the early weeks of treatment, during which the sleep restriction component of CBT-I may temporarily worsen sleep before improving it. Some medications, including low-dose tricyclic antidepressants (amitriptyline) and trazodone, are used long-term for insomnia with comorbid depression or anxiety, providing dual-purpose treatment.
Types of Sleep Medications and Their Roles
Benzodiazepine receptor agonists (Z-drugs: zolpidem, zaleplon, eszopiclone) are the most commonly prescribed sleep medications. They promote sleep onset and maintenance by enhancing GABA activity. They are effective for short-term use (2–4 weeks) but lose efficacy with regular use, can cause next-day sedation, and carry risks of tolerance, dependence, and rebound insomnia on discontinuation. They are not recommended for long-term use in chronic insomnia.
Orexin receptor antagonists (suvorexant, lemborexant, daridorexant) are a newer class that block the wake-promoting orexin system rather than sedating the brain globally. They have a better safety profile than benzodiazepines — lower risk of dependence, rebound, and cognitive impairment — and are approved for longer-term use. Melatonin receptor agonists (ramelteon) are non-sedating and target the circadian system; they are appropriate for sleep onset delay and have very low abuse potential.
When Medication Is Not the Right Choice
Sleep medication is not appropriate as long-term primary treatment for chronic insomnia disorder. Guidelines are clear that CBT-I produces superior and more durable outcomes for chronic insomnia, without the risks of tolerance, dependence, and residual sedation that most hypnotics carry. Medication does not address the psychological and behavioral perpetuating factors of insomnia — it chemically induces sleep but leaves the underlying disorder intact.
Sleep medication is generally contraindicated in sleep apnea (most hypnotics worsen respiratory depression and apnea severity), in pregnancy, in the elderly (particularly benzodiazepines and Z-drugs, which significantly increase fall risk), and in people with substance use disorders. Discussing your complete medical history with your prescribing physician ensures that medication is appropriate for your specific situation.
When to Speak With a Doctor
If you are considering or currently using sleep medication, discuss its appropriateness for your specific diagnosis, duration of use, and available alternatives — particularly CBT-I — with your doctor. A medication review is especially important if you have been using a sleep medication regularly for more than 4 weeks.
Frequently Asked Questions
References
- [1]Sateia MJ et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults. J Clin Sleep Med. 2017.
- [2]Qaseem A et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016.
The information on this page is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.